Ardelyx | ARDX - Current Liabilities

Stock Price
5.95
Daily Change
-0.01 -0.17%
Monthly
5.50%
Yearly
13.12%
Q2 Forecast
5.82

Ardelyx reported $88.6M in Current Liabilities for its fiscal quarter ending in December of 2025.





Current Liabilities Change Date
Abbott USD 16.5B 1.91B Dec/2025
Amgen USD 25.49B 3.7B Dec/2025
Ardelyx USD 88.6M 5.22M Dec/2025
aTyr Pharma USD 113.19M 97.51M Dec/2025
Corcept Therapeutics USD 166.08M 6.18M Dec/2025
Curis USD 14.08M 5.3M Dec/2025
Sanofi EUR 28.35B 9.32B Dec/2025
TG Therapeutics USD 153.76M 3.05M Dec/2025
United Therapeutics USD 560.6M 14.3M Dec/2025
Xoma USD 28.3M 6.81M Sep/2025